Reply to an Answer

In response to:

Metastatic disease to the bone is a bad prognostic event and implies advanced prostate cancer. Complete androgen blockade (an LHRH agent as well as an anti-androgen such as Casodex) is needed to best control the disease. Unfortunately, over time patients with advanced disease tend to stop responding to these therapies. At that time the PSA will start to rise and therapy will be changed. Due to your advanced disease and relatively young age, it my be a reasonable approach to look into clinical research trials that are ongoing which may offer other suitable alternatives.

Subject:

Comment:

Display Name:

Note: This Display Name will be publicly visible on your SharePosts, your profile on this site, and the rest of the Internet. To maintain your anonymity do not include personally identifiable information (such as your name or email address) in your Display Name, SharePosts, or any other public postings on our site.

Role:

Email Address:

Password:

Confirm password:

Type the letters shown in the box to the right:

Accept Our Terms of Service

Please send me news updates, top features and
highlights via the ProstateCommons.com newsletter.
View sample.

Email:

Password:

Remember Me:

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on ProstateCommons.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.

Sign in

ProstateCommons.com

Reply to an Answer